Envestnet Asset Management’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,088
Closed -$61K 4065
2022
Q2
$61K Buy
1,088
+3
+0.3% +$164 ﹤0.01% 3801
2022
Q1
$64K Buy
+1,085
New +$55.2K ﹤0.01% 3842
2021
Q2
Sell
-422
Closed -$30K 3709
2021
Q1
$30K Buy
422
+40
+10% +$3.12K ﹤0.01% 3471
2020
Q4
$25K Buy
+382
New +$18.3K ﹤0.01% 3251
2020
Q3
Sell
-1,317
Closed -$59K 3206
2020
Q2
$59K Buy
1,317
+299
+29% +$13.5K ﹤0.01% 3019
2020
Q1
$48K Buy
+1,018
New +$47.9K ﹤0.01% 2905

Other funds holding NTBL

Envestnet Asset Management's NTBL Position: Q3 2022 in Review

Envestnet Asset Management sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q3 2022, closing a stake of 1,088 shares — an estimated $61K sold.

Envestnet Asset Management first reported a position in NTBL in Q1 2020 and held it in 6 quarters. The position peaked at $64K in Q1 2022. 26 funds tracked by Wall St. Rank hold NTBL as of Q3 2022.

  • Envestnet Asset Management reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 1,088 Notable Labs, Ltd. Ordinary Shares shares in Q3 2022, an estimated $61K.
  • Envestnet Asset Management first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2020 and held it in 6 quarters.
  • Envestnet Asset Management's Notable Labs, Ltd. Ordinary Shares position peaked at $64K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q3 2022.

Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.